Pim1 Serine/Threonine Kinase Regulates the Number and Functions of Murine Hematopoietic Stem Cells
暂无分享,去创建一个
A. Kraft | S. Mahajan | Zihai Li | Yingwei Lin | Yong Wang | Yubin Kang | J. Kellner | Ningfei An
[1] Yubin Kang,et al. Using quantitative real-time PCR to determine donor cell engraftment in a competitive murine bone marrow transplantation model. , 2013, Journal of visualized experiments : JoVE.
[2] Masayuki Yamamoto,et al. Contribution of GATA1 dysfunction to multi‐step leukemogenesis , 2012, Cancer science.
[3] S. Nilsson,et al. Bone, microenvironment and hematopoiesis , 2012, Current opinion in hematology.
[4] F. Giles,et al. The PIM kinases in hematological cancers , 2012, Expert review of hematology.
[5] A. Kraft,et al. The Pim protein kinases regulate energy metabolism and cell growth , 2010, Proceedings of the National Academy of Sciences.
[6] Kwok-Kin Wong,et al. Mitigation of hematologic radiation toxicity in mice through pharmacological quiescence induced by CDK4/6 inhibition. , 2010, The Journal of clinical investigation.
[7] Jeffrey K. Mito,et al. Selective Enhancement of Donor Hematopoietic Cell Engraftment by the CXCR4 Antagonist AMD3100 in a Mouse Transplantation Model , 2010, PloS one.
[8] Stefan Knapp,et al. PIM serine/threonine kinases in the pathogenesis and therapy of hematologic malignancies and solid cancers , 2010, Haematologica.
[9] J. Chi,et al. Pleiotrophin regulates the expansion and regeneration of hematopoietic stem cells , 2010, Nature Medicine.
[10] W. Matsui,et al. Gli1 regulates the proliferation and differentiation of HSCs and myeloid progenitors. , 2010, Blood.
[11] Lijian Shao,et al. Slug deficiency enhances self-renewal of hematopoietic stem cells during hematopoietic regeneration. , 2010, Blood.
[12] Ying-Wei Lin,et al. A small molecule inhibitor of Pim protein kinases blocks the growth of precursor T-cell lymphoblastic leukemia/lymphoma. , 2010, Blood.
[13] Mark A Sussman,et al. Enhancement of Myocardial Regeneration Through Genetic Engineering of Cardiac Progenitor Cells Expressing Pim-1 Kinase , 2009, Circulation.
[14] Stefan Knapp,et al. Dissection of PIM serine/threonine kinases in FLT3-ITD–induced leukemogenesis reveals PIM1 as regulator of CXCL12–CXCR4-mediated homing and migration , 2009, The Journal of experimental medicine.
[15] G. Smyth,et al. ELDA: extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays. , 2009, Journal of immunological methods.
[16] Lisa S. Chen,et al. Pim kinase inhibitor, SGI-1776, induces apoptosis in chronic lymphocytic leukemia cells. , 2008, Blood.
[17] S. Salati,et al. Signal control of hematopoietic stem cell fate: Wnt, Notch, and Hedgehog as the usual suspects , 2008, Current opinion in hematology.
[18] T. Kitamura,et al. Efficient retroviral transduction of human B-lymphoid and myeloid progenitors: marked inhibition of their growth by the Pax5 transgene , 2008, International journal of hematology.
[19] G. de Haan,et al. In vitro assays for cobblestone area-forming cells, LTC-IC, and CFU-C. , 2008, Methods in molecular biology.
[20] Marielle Afanassieff,et al. Self‐Renewal of Murine Embryonic Stem Cells Is Supported by the Serine/Threonine Kinases Pim‐1 and Pim‐3 , 2007, Stem cells.
[21] D. Largaespada,et al. Vav promoter-tTA conditional transgene expression system for hematopoietic cells drives high level expression in developing B and T cells. , 2007, Experimental hematology.
[22] E. Passegué,et al. Evidence that the Pim1 kinase gene is a direct target of HOXA9. , 2007, Blood.
[23] P. Quesenberry,et al. Murine allogeneic in vivo stem cell homing , , 2007, Journal of cellular physiology.
[24] K. Tsuneyama,et al. Proto‐oncogene, Pim‐3 with serine/threonine kinase activity, is aberrantly expressed in human colon cancer cells and can prevent Bad‐mediated apoptosis , 2007, Cancer science.
[25] E. Passegué,et al. Evidence that the Pim 1 kinase gene is a direct target of HOXA 9 , 2007 .
[26] Hiroshi Ishikura,et al. Pim-3, a proto-oncogene with serine/threonine kinase activity, is aberrantly expressed in human pancreatic cancer and phosphorylates bad to block bad-mediated apoptosis in human pancreatic cancer cell lines. , 2006, Cancer research.
[27] B. Storer,et al. Competing Interests: The authors , 2004 .
[28] T. Möröy,et al. The oncogenic serine/threonine kinase Pim-1 directly phosphorylates and activates the G2/M specific phosphatase Cdc25C. , 2006, The international journal of biochemistry & cell biology.
[29] J. Arthur,et al. Pim kinases phosphorylate multiple sites on Bad and promote 14-3-3 binding and dissociation from Bcl-XL , 2006, BMC Cell Biology.
[30] A. Kraft,et al. Pim Family Kinases Enhance Tumor Growth of Prostate Cancer Cells , 2005, Molecular Cancer Research.
[31] S. E. Jacobsen,et al. Identification of Lin(-)Sca1(+)kit(+)CD34(+)Flt3- short-term hematopoietic stem cells capable of rapidly reconstituting and rescuing myeloablated transplant recipients. , 2005, Blood.
[32] P. Koskinen,et al. Pim‐1 kinase promotes inactivation of the pro‐apoptotic Bad protein by phosphorylating it on the Ser112 gatekeeper site , 2004, FEBS letters.
[33] Jos Jonkers,et al. Mice Deficient for All PIM Kinases Display Reduced Body Size and Impaired Responses to Hematopoietic Growth Factors , 2004, Molecular and Cellular Biology.
[34] Anton Berns,et al. High-throughput retroviral tagging to identify components of specific signaling pathways in cancer , 2002, Nature Genetics.
[35] T. Kitamura,et al. Pim-1 expression is sufficient to induce cytokine independence in murine hematopoietic cells, but is dispensable for BCR-ABL-mediated transformation. , 2002, Experimental hematology.
[36] M. Schebesta,et al. Transcriptional control of B-cell development. , 2002, Current opinion in immunology.
[37] J. Kolls,et al. Chimerism analysis in sex-mismatched murine transplantation using quantitative real-time PCR. , 2002, BioTechniques.
[38] Z. Wang,et al. Pim-1: a serine/threonine kinase with a role in cell survival, proliferation, differentiation and tumorigenesis. , 2001, Journal of veterinary science.
[39] S. Jacobsen,et al. Upregulation of Flt3 expression within the bone marrow Lin(-)Sca1(+)c-kit(+) stem cell compartment is accompanied by loss of self-renewal capacity. , 2001, Immunity.
[40] D. Wojchowski,et al. Pim-1 kinase protects hematopoietic FDC cells from genotoxin-induced death , 2000, Oncogene.
[41] R Grosschedl,et al. Wnt signaling regulates B lymphocyte proliferation through a LEF-1 dependent mechanism. , 2000, Immunity.
[42] C. Albanese,et al. The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[43] J. Visvader,et al. Transcriptional regulation of vav, a gene expressed throughout the hematopoietic compartment. , 1998, Blood.
[44] A. Kraft,et al. Enforced expression of the Mr 33,000 Pim-1 kinase enhances factor-independent survival and inhibits apoptosis in murine myeloid cells. , 1997, Cancer research.
[45] A. Berns,et al. Pim-2 transgene induces lymphoid tumors, exhibiting potent synergy with c-myc , 1997, Oncogene.
[46] P. Laird,et al. Pim-1 levels determine the size of early B lymphoid compartments in bone marrow , 1993, The Journal of experimental medicine.
[47] P. Laird,et al. In vivo analysis of Pim-1 deficiency. , 1993, Nucleic acids research.
[48] F. Sigaux,et al. The human protooncogene product p33pim is expressed during fetal hematopoiesis and in diverse leukemias. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[49] A. Berns,et al. Evidence for the involvement of pim‐2, a new common proviral insertion site, in progression of lymphomas. , 1989, The EMBO journal.
[50] A. Berns,et al. Predisposition to lymphomagenesis in pim-1 transgenic mice: Cooperation with c-myc and N-myc in murine leukemia virus-induced tumors , 1989, Cell.
[51] Wim Quint,et al. Murine leukemia virus-induced T-cell lymphomagenesis: Integration of proviruses in a distinct chromosomal region , 1984, Cell.